Skip to main content
. 2023 Jan 13;15(2):500. doi: 10.3390/cancers15020500

Table 1.

Demographic characteristics and clinical-pathologic data. PDS: primary debulking surgery; IDS: interval debulking surgery; FIGO: International Federation of Gynecology and Obstetrics; HGSOC: high grade serous ovarian cancer; EBL: estimated blood loss.

Variables Total PDS IDS p *
Age years, median (range) 59.6 (28–90) 59 (35–90) 61 (28–80) 0.22
Body Mass Index, median (range) 26.2 (17–51) 26.2 (17–51) 26.3 (18–44) 0.63
Pre-operative CA 125 (UI/mL)
Negative, n (%) 7 (7.1%) 7 (10.4%) 0 (0%) 0.67
<500 UI/mL, n (%) 35 (35.7%) 23 (34.3%) 12 (38.7%)
≥500 UI/mL, n (%) 56 (57.1%) 37 (55.2%) 19 (61.3%)
FIGO stage
IIIA, n (%) 9 (9%) 9 (13%) 0 (0%) 0.001
IIIB, n (%) 5 (5%) 5 (7.2%) 0 (0%)
IIIC, n (%) 61 (61%) 47 (68.2%) 17 (54.8%)
IVA, n (%) 5 (5%) 2 (2.9%) 3 (9.7%)
IVB, n (%) 17 (17%) 6 (8.7%) 11 (35.5%)
Histology
HGSOC, n (%) 83 (83%) 54 (78.3%) 29 (93.5%) 0.06
Non-HGSOC, n (%) 17 (17%) 15 (21.7%) 2 (6.5%)
Surgical complexity score
1, n (%) 11 (11%) 6 (8.7%) 5 (16.1%) 0.28
2, n (%) 21 (21%) 14 (20.3%) 7 (22.6%)
3, n (%) 68 (68%) 49 (71%) 19 (61.3%)
Residual Disease
R0, n (%) 74 (74%) 50 (72.5%) 24 (77.4%) 0.51
R1 (0.1–1 cm), n (%) 22 (22%) 15 (21.7%) 7 (22.6%)
R2 (>1 cm), n (%) 4 (4%) 4 (5.8%) 0 (0%)
Upper abdomen procedures (UAP)
Yes 84 (84%) 58 (84.1%) 26 (83.9%) 0.98
No 16 (16%) 11 (15.9%) 5 (16.1%)
Operative time (min), median (range) 422.5 (90–870) 421.5 (90–870) 424.7 (170–700) 0.74
EBL (mL), median (range) 428.9 (50–2000) 460.9 (50–2000) 362.9 (50–900) 0.36
Number of intra-operative transfusion (n), median (range) 0.4 (0–1) 0.4 (0–1) 0.5 (0–1) 0.7
Length of hospital stay (days **), median (range) 17.4 (0–68) 18 (0–68) 16.1 (3–60) 0.54

* Categorical data were compared with the χ2 test or Fisher’s exact test, as appropriate. The Mann–Whitney test was used to compare continuous variables. ** Calculated from the hospital admission to discharge after final surgery.